This research service presents an overview and analysis of the non-small cell lung cancer drug market in Indonesia from 2010 to 2015. It provides an analysis of the patient load, typical treatment regimens, clinical trial statistics, and treatment challenges. Along with this coverage, the research service also outlines market drivers and restraints, market engineering measurements, and market trends. The research service ends with a market analysis, which includes the competitive structure, and industry megatrends. Primary interviews were conducted with Indonesia's key opinion leaders in medical oncology and pulmonology, the National Cancer Center, and manufacturers, in order to obtain insight into the market landscape and market trends.